United StatesBoston Scientific, a medical device manufacturer, reported earnings that exceeded expectations for the second quarter. However, the company has revised its annual profit forecast downward, projecting adjusted earnings per share (EPS) between $3.28 and $3.32 for the full year, compared to a previous estimate of $3.34 to $3.41. This revision reflects the company’s updated financial outlook despite the positive quarterly results. The change in forecast could impact investor confidence and stock performance, particularly if the lower-than-expected guidance leads to market concerns about the company's future profitability.
Bias read (Center): The article reports on a corporate earnings update and revised profit forecast, which falls under business news. There is no indication of political framing, bias, or controversy in the content. The information presented is straightforward and factual, focusing solely on financial performance.
